{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18926814", "DateCompleted": {"Year": "2009", "Month": "03", "Day": "27"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.ejphar.2008.09.031"], "ArticleDate": [{"Year": "2008", "Month": "09", "Day": "30"}], "Journal": {"ISSN": "1879-0712", "JournalIssue": {"Volume": "600", "Issue": "1-3", "PubDate": {"Year": "2008", "Month": "Dec", "Day": "14"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.", "Pagination": {"StartPage": "117", "EndPage": "122", "MedlinePgn": "117-22"}, "Abstract": {"AbstractText": ["Ozone is a potent oxidant and causes airway hyperresponsiveness and neutrophilia. To determine the role of p38 mitogen-activated protein kinase (MAPK) activation, we studied the effect of a p38alpha inhibitor SD-282 (Scios Inc, Fremont, CA USA) on ozone-induced airway hyperresponsiveness and neutrophilia. Balb/c mice received SD-282 (30 or 90 mg/kg i.p) or vehicle 1 h before exposure to either ozone (3 ppm, 3 h) or air. Three hours after exposure, lungs were analysed for cytokine levels and bronchoalveolar lavage was performed. Another set of mice were dosed 6 h after exposure and 1 h before assessing airway hyperresponsiveness. SD-282 (90 mg/kg) significantly inhibited ozone-induced airway hyperresponsiveness (-LogPC(150): SD-282: -1.73+/-0.14 vs. vehicle: -0.99+/-0.15, P<0.05). Bronchoalveolar lavage neutrophil numbers were time-dependently increased in vehicle-dosed, ozone-exposed mice, greatest at 20-24 h after exposure. SD-282 (30 and 90 mg/kg) significantly inhibited ozone induced neutrophil numbers at 3 h and 20-24 h after ozone SD-282 significantly inhibited ozone-induced increases in phosphorylated p38 MAPK expression, and in cyclooxygenase-2 (COX-2), interleukin-6 (IL-6) and IL-1beta but not MIP-1alpha gene expression. We conclude that p38 MAPK is involved in ozone-induced airway hyperresponsiveness and lung neutrophilia. Inhibition of p38 MAPK with small molecule kinase inhibitors may be a means of reducing ozone-induced inflammation and airway hyperresponsiveness."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK."}], "Identifier": [], "LastName": "Williams", "ForeName": "Alison S", "Initials": "AS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Issa", "ForeName": "Razao", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Durham", "ForeName": "Andrew", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leung", "ForeName": "Sum-Yee", "Initials": "SY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kapoun", "ForeName": "Ann", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Medicherla", "ForeName": "Satyanarayana", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Higgins", "ForeName": "Linda S", "Initials": "LS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adcock", "ForeName": "Ian M", "Initials": "IM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "Kian Fan", "Initials": "KF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Indoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "indole-5-carboxamide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "p38 Mitogen-Activated Protein Kinases"}], "CommentsCorrectionsList": [{"RefSource": "Eur J Pharmacol. 2009 May 1;609(1-3):155-6"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "physiopathology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Indoles"}, {"QualifierName": ["chemically induced", "physiopathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "p38 Mitogen-Activated Protein Kinases"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "4", "Day": "29"}, {"Year": "2008", "Month": "9", "Day": "3"}, {"Year": "2008", "Month": "9", "Day": "23"}, {"Year": "2008", "Month": "10", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "3", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "10", "Day": "18", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18926814", "10.1016/j.ejphar.2008.09.031", "S0014-2999(08)00971-0"]}}], "PubmedBookArticle": []}